AVBP logo

ArriVent BioPharma (AVBP) Operating Profit

Annual Operating Profit

-$94.31 M
-$19.72 M-26.44%

December 31, 2024


Summary


Performance

AVBP Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPprofitabilitymetrics:

Quarterly Operating Profit

-$23.70 M
+$527.00 K+2.17%

December 31, 2024


Summary


Performance

AVBP Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPprofitabilitymetrics:

TTM Operating Profit

-$94.31 M
-$587.00 K-0.63%

December 31, 2024


Summary


Performance

AVBP TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

AVBP Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-26.4%+7.8%-9.4%
3 y3 years-+7.8%-9.4%
5 y5 years-+7.8%-9.4%

AVBP Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-155.5%at low-127.0%+7.8%-701.4%at low
5 y5-year-155.5%at low-127.0%+7.8%-701.4%at low
alltimeall time-155.5%at low-127.0%+7.8%-701.4%at low

ArriVent BioPharma Operating Profit History

DateAnnualQuarterlyTTM
Dec 2024
-$94.31 M(+26.4%)
-$23.70 M(-2.2%)
-$94.31 M(+0.6%)
Sep 2024
-
-$24.23 M(-5.7%)
-$93.72 M(+8.7%)
Jun 2024
-
-$25.70 M(+24.3%)
-$86.20 M(+3.7%)
Mar 2024
-
-$20.67 M(-10.6%)
-$83.09 M(+11.4%)
Dec 2023
-$74.59 M
-$23.12 M(+38.3%)
-$74.59 M(+20.5%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$16.72 M(-26.0%)
-$61.91 M(+8.7%)
Jun 2023
-
-$22.58 M(+85.5%)
-$56.97 M(+65.7%)
Mar 2023
-
-$12.17 M(+16.6%)
-$34.38 M(+54.8%)
Dec 2022
-$36.91 M
-
-
Dec 2022
-
-$10.44 M(-11.3%)
-$22.21 M(+88.7%)
Sep 2022
-
-$11.77 M
-$11.77 M

FAQ

  • What is ArriVent BioPharma annual operating income?
  • What is the all time high annual operating profit for ArriVent BioPharma?
  • What is ArriVent BioPharma annual operating profit year-on-year change?
  • What is ArriVent BioPharma quarterly operating income?
  • What is the all time high quarterly operating profit for ArriVent BioPharma?
  • What is ArriVent BioPharma quarterly operating profit year-on-year change?
  • What is ArriVent BioPharma TTM operating income?
  • What is the all time high TTM operating profit for ArriVent BioPharma?
  • What is ArriVent BioPharma TTM operating profit year-on-year change?

What is ArriVent BioPharma annual operating income?

The current annual operating profit of AVBP is -$94.31 M

What is the all time high annual operating profit for ArriVent BioPharma?

ArriVent BioPharma all-time high annual operating income is -$36.91 M

What is ArriVent BioPharma annual operating profit year-on-year change?

Over the past year, AVBP annual operating income has changed by -$19.72 M (-26.44%)

What is ArriVent BioPharma quarterly operating income?

The current quarterly operating profit of AVBP is -$23.70 M

What is the all time high quarterly operating profit for ArriVent BioPharma?

ArriVent BioPharma all-time high quarterly operating income is -$10.44 M

What is ArriVent BioPharma quarterly operating profit year-on-year change?

Over the past year, AVBP quarterly operating income has changed by +$1.99 M (+7.75%)

What is ArriVent BioPharma TTM operating income?

The current TTM operating profit of AVBP is -$94.31 M

What is the all time high TTM operating profit for ArriVent BioPharma?

ArriVent BioPharma all-time high TTM operating income is -$11.77 M

What is ArriVent BioPharma TTM operating profit year-on-year change?

Over the past year, AVBP TTM operating income has changed by -$8.10 M (-9.40%)